Clinical Trials Browser

Completed × Muscular Atrophy × Clear all

Lymphoma, Multiple Myeloma, Muscular Atrophy, Hematologic Neoplasms

NCT06175273 2025-09-18

POINT

Phase 2/3 Completed

19 enrolled

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

NCT04299048 2023-12-14

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

Phase 1 Completed

11 enrolled 13 charts

GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Muscular Atrophy, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT04207359 2023-07-25

Effects of Creatine Supplementation in Breast Cancer Survivors

Phase NA Completed

20 enrolled

Breast

Breast Neoplasms, Motor Activity, Muscular Atrophy, Muscle Weakness

NCT03960034 2022-04-15

LUCAX01

Completed

60 enrolled

Thoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Muscular Atrophy

NCT04266015 2022-04-15

Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery

Phase NA Completed

60 enrolled

Head & Neck

Intermittent Fasting, Fasting, Head and Neck Neoplasms, Muscular Atrophy, Postoperative Complications

NCT04911972 2021-12-13

Functional Muscle Transfers in Lower Limb Sarcoma: 3D Gait Analysis and Environmental Simulation

Completed

27 enrolled

Sarcoma

Muscular Atrophy, Sarcoma, Muscle Neoplasms

NCT05088304 2021-10-21

GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer

Completed

205 enrolled

Gastrointestinal

Esophageal Neoplasms, Muscular Atrophy, Neoplasms, Postoperative Complications, Stomach Neoplasms, Malnutrition

NCT01355497 2020-11-09

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

Phase 3 Completed

330 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Muscular Atrophy

NCT02293239 2018-10-16

Effects of WB-EMS and Dietetic Treatment on Cancer Patients

Phase NA Completed

278 enrolled

Cachexia, Muscular Atrophy, Neoplasms, Weight Loss, Muscle Weakness

NCT01047163 2016-04-27

Maintenance of Muscle Mass in Older People: the Negative Impact of Statin Therapy

Completed

18 enrolled

Endocrine

Muscular Atrophy, Muscular Diseases, Multiple Endocrine Neoplasia Type 1, Myalgia

NCT01355484 2016-03-03

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Completed

321 enrolled 7 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Muscular Atrophy

NCT02052024 2015-12-16

MAS

Phase 4 Completed

10 enrolled

Brain Injuries, Muscle Spasticity, Muscular Atrophy, Neoplasms, Spinal Cord Injuries, Wounds and Injuries, Stroke

NCT00467844 2014-07-11

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Phase 2 Completed

159 enrolled 11 charts

GastrointestinalLymphoidThoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin, Muscular Atrophy, Colorectal Neoplasms

NCT00196885 2008-06-20

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training

Phase 2 Completed

60 enrolled

GastrointestinalLymphoid

Carcinoma, Bronchogenic, Gastrointestinal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Muscular Atrophy, Weight Loss

Clinical Trials

Muscle Stimulation for Physical Function During Stem Cell Transplant

POINT

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

Effects of Creatine Supplementation in Breast Cancer Survivors

LUCAX01

Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery

Functional Muscle Transfers in Lower Limb Sarcoma: 3D Gait Analysis and Environmental Simulation

GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

Effects of WB-EMS and Dietetic Treatment on Cancer Patients

Maintenance of Muscle Mass in Older People: the Negative Impact of Statin Therapy

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

MAS

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training